In recent months, we have had many discussions with manufacturers about electronic Quality Management Systems (eQMS). Interestingly, the conversations often start the same way.
Companies feel they have simply outgrown their current setup. What once worked well, perhaps a SharePoint folder, a local server, or even documentation stored on a laptop in the corner of the office, no longer feels sustainable.
As organisations grow, professionalise, and prepare for commercialization, the limits of informal systems become visible.
The question is no longer whether documentation exists. It becomes whether the system supporting it is scalable, secure, and ready for scrutiny.
Growth changes the equation
For a small early-stage team with minimal documentation and no active audits, lightweight solutions can be sufficient. However, once audits begin, product portfolios expand, or technical documentation grows in volume and complexity, manual systems quickly become resource-intensive.
Many companies underestimate the internal cost of not using an eQMS. Managing certifications, maintaining QMS documentation, controlling technical files, and tracking changes through spreadsheets or shared folders often requires significant employee time.
If several team members are spending large portions of their workload maintaining manual documentation systems, the true cost may already exceed that of a well-selected eQMS platform.
Investor expectations and due diligence
Another common trigger for eQMS discussions is external pressure. Companies preparing for investment rounds, mergers, or acquisitions are increasingly asked about their infrastructure.
A structured and scalable documentation system demonstrates operational maturity. From an investor perspective, a properly implemented eQMS signals that compliance, traceability, and document control are embedded in the company’s culture.
It can also simplify due diligence processes. When documentation is structured, searchable, and systematically controlled, external review becomes significantly smoother.
An eQMS is therefore not only a compliance tool, but also a strategic asset.
Addressing the two biggest concerns: cost and implementation
Two major concerns consistently arise in these discussions.
The first is cost. Companies worry about subscription fees, licensing models, and hidden implementation expenses. The second is fear of poor implementation. A badly configured system can create frustration, resistance, and inefficiency.
Both concerns are valid.
However, many modern eQMS platforms offer flexible pricing structures that make them accessible even to smaller organisations. The larger risk often lies not in the platform cost itself, but in underestimating the internal cost of inefficient documentation management.
Equally important is implementation. A structured, well-planned implementation significantly reduces risk. Reassurance, clarity of scope, and alignment with company processes are essential.
When implemented properly, an eQMS reduces administrative burden rather than increasing it.
Integration: not always necessary
Another frequent question concerns system integration. Companies often assume that an eQMS must be integrated with every other system from day one.
In reality, systems can often run separately. Integration should only be pursued when there is a clear operational benefit. Premature integration can be expensive and complex.
A pragmatic, step-by-step approach usually provides better long-term results.
When should you “pull the trigger”?
There is no universal threshold, but certain indicators are clear.
If your organisation:
-
is undergoing or preparing for audits,
-
manages a growing portfolio of devices,
-
maintains full technical documentation under MDR, IVDR, or FDA requirements,
-
or is preparing for investor scrutiny,
then moving to an eQMS is often a logical step.
If you are just starting your QMS journey, embedding an eQMS early can also shape company culture. Documentation management becomes structured from the beginning, reducing the need for later migration and restructuring.
Choosing the right platform
Not all eQMS platforms are equal. At minimum, the platform should be ISO 27001 certified, ensuring appropriate information security standards.
It is also essential that the system’s structure and templates align with the regulatory pathways relevant to your device. For example, support for FDA 21 CFR Part 820, MDR, IVDR, or other applicable standards should be reflected in system capabilities.
Selecting a platform that supports your intended market strategy prevents costly reconfiguration later.
A strategic investment, not just a compliance tool
An eQMS is often perceived as a regulatory necessity. In practice, it can become a strategic enabler.
A well-chosen and properly implemented system:
-
reduces administrative burden,
-
improves traceability and control,
-
strengthens audit readiness,
-
supports investor confidence,
-
and creates a scalable foundation for growth.
The key is approaching the decision thoughtfully, with a clear understanding of both regulatory requirements and business objectives.
How MDS can support you
At MDS, we support medical device manufacturers in selecting, implementing, and optimising eQMS solutions that fit their size, maturity, and regulatory pathway.
Our goal is not to push a specific platform, but to ensure that your system supports compliance, operational efficiency, and long-term growth.
If you are considering moving to an eQMS, or reassessing your current solution, we are happy to discuss your situation. You can contact us at Kristian@mdsdenmark.dk or schedule a consultation via Book a Meeting.